Delivery Order SPE2DB20D3101-SPE2DB23FRVR6
Award Date
8/23/23
Potential Completion Date
8/24/23
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,072.37 for the supply of Lacosamide 10 mg/ml solution. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 22, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Lacosamide 10 mg/mL solution in 200 mL bottles to the Defense Logistics Agency (DLA). The contract, valued at $1,574.15, was awarded to the Amerisourcebergen Drug Corporation's Corporate Office Division on April 23, 2024, with a completion date of April 24, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. Amerisourcebergen Drug Corporation is a major pharmaceutical distributor that holds a...
This federal contract award, with ID SPE2DB20D1050|SPE2DB24FH46J, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lacosamide 10 mg/ml solution, a pharmaceutical product, with a ceiling value of $1,285.61 and a period of performance through January 12, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4565662476 Lacosamide 10 mg/ml solution in 200 ml containers. The contract has a ceiling value of $1,013.31 and is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price arrangement with no set-aside designation. It has an ultimate completion date of September 4, 2024. Amerisourcebergen, one of the largest pharmaceutical...
This federal contract award, valued at $1,037.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,947,538 units of Lacosamide 150 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lacosamide 10 mg/ml solution, a pharmaceutical product, with a ceiling value of $1,045.92 and a completion date of January 21, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563830313 - Lacosamide 10 mg/ml solution 200 ml. The contract has a completion date of March 4, 2024 and a potential value of $1,450.26. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger indefinite delivery contract (IDC) between...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Lacosamide 10 mg/ml solution 200ml. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a firm fixed price ceiling value of $1,657.44 and a completion date of May 13, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December...
This award is for a Delivery Order contract with Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide Lacosamide 50 mg/5 ml cup UD 5 ml to the U.S. Department of Defense's Medical Supply Chain. The award has a ceiling value of $3,000.36 and an ultimate completion date of June 11, 2024. The contract is a Firm Fixed Price arrangement, without any set-aside designations. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the Defense...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lacosamide 10 mg/ml solution in 200 ml containers, with a ceiling value of $1,205.88. It is a firm fixed-price contract with a final completion date of July 31, 2024. The contract is not set-aside and was awarded on July 30, 2024. AmerisourceBergen, through its extensive supply chain network, will provide...